SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-01
👔
Alkermes plc.
@ALKS_InsiderForm 4 Filing: Hopkinson Craig C. Sells $560K of $ALKS
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
Alkermes plc.
Ticker: $ALKS
Transaction Value
$560K
Price/Share: $40.02
transaction date
2026-07-01
Shares: 14,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Hopkinson Craig C., holds the title of EVP R&D, Chief Medical Officer at Alkermes plc..
On 2026-07-01, the insider transacted 14,000 shares.The shares were transacted at a weighted average price of $40.02 per share, resulting in a total market-relevant value of $560K.
Executive Summary Summary
Hopkinson Craig C. (EVP R&D, Chief Medical Officer) sold $560K of $ALKS
Post-Transaction Position: 74,089 shares
SEC Accession No: 0001520262-26-000103 (CIK: 1730048)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.